Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Total Debt Summary of Vetoquinol SA

Vetoquinol SA's latest annual total debt in 2023 was 17.62 Million EUR , up 1.19% from previous year.
Vetoquinol SA's latest quarterly total debt in 2024 Q2 was 6.29 Million EUR , down 0.0% from previous quarter.
Vetoquinol SA reported annual total debt of 17.42 Million EUR in 2022, up 13.25% from previous year.
Vetoquinol SA reported annual total debt of 15.38 Million EUR in 2021, down -87.68% from previous year.
Vetoquinol SA reported quarterly total debt of 17.62 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Vetoquinol SA reported quarterly total debt of 17.62 Million EUR for 2023 FY, up 1.19% from previous quarter.

Annual Total Debt Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Total Debt of Vetoquinol SA (2023 - 2005)

Year	Total Debt	Total Debt Growth
2023	17.62 Million EUR	1.19%
2022	17.42 Million EUR	13.25%
2021	15.38 Million EUR	-87.68%
2020	124.85 Million EUR	933.06%
2019	12.08 Million EUR	81.09%
2018	6.67 Million EUR	-56.75%
2017	15.43 Million EUR	-36.44%
2016	24.27 Million EUR	-27.2%
2015	33.34 Million EUR	-41.73%
2014	57.22 Million EUR	54.22%
2013	37.1 Million EUR	-26.36%
2012	50.38 Million EUR	59.61%
2011	31.57 Million EUR	-6.56%
2010	33.78 Million EUR	24.59%
2009	27.11 Million EUR	315.0%
2008	6.53 Million EUR	0.0%
2007	- EUR	-100.0%
2006	42.49 Million EUR	-16.64%
2005	50.97 Million EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	6.29 Million EUR	0.0%
2023 Q4	17.62 Million EUR	0.0%
2023 FY	17.62 Million EUR	1.19%
2023 Q2	15.81 Million EUR	0.0%
2022 Q4	17.42 Million EUR	0.0%
2022 Q2	19.73 Million EUR	0.0%
2022 FY	17.42 Million EUR	13.25%
2021 Q2	34.93 Million EUR	0.0%
2021 Q4	15.38 Million EUR	0.0%
2021 FY	15.38 Million EUR	-87.68%
2020 Q2	9.87 Million EUR	0.0%
2020 Q4	124.85 Million EUR	0.0%
2020 FY	124.85 Million EUR	933.06%
2019 FY	12.08 Million EUR	81.09%
2019 Q2	14 Million EUR	0.0%
2019 Q4	12.08 Million EUR	0.0%
2018 FY	6.67 Million EUR	-56.75%
2018 Q4	6.67 Million EUR	0.0%
2018 Q2	11.49 Million EUR	0.0%
2017 FY	15.43 Million EUR	-36.44%
2017 Q4	15.43 Million EUR	0.0%
2017 Q2	20.16 Million EUR	0.0%
2016 Q2	29.34 Million EUR	0.0%
2016 FY	24.27 Million EUR	-27.2%
2016 Q4	24.67 Million EUR	0.0%
2015 FY	33.34 Million EUR	-41.73%
2015 Q2	58.03 Million EUR	0.0%
2015 Q4	33.34 Million EUR	0.0%
2014 Q2	65.29 Million EUR	0.0%
2014 FY	57.22 Million EUR	54.22%
2014 Q4	57.22 Million EUR	0.0%
2013 Q4	37.1 Million EUR	0.0%
2013 FY	37.1 Million EUR	-26.36%
2013 Q2	55.08 Million EUR	0.0%
2012 Q4	50.38 Million EUR	0.0%
2012 Q2	- EUR	0.0%
2012 FY	50.38 Million EUR	59.61%
2011 Q4	31.57 Million EUR	0.0%
2011 FY	31.57 Million EUR	-6.56%
2010 Q2	30.09 Million EUR	0.0%
2010 Q4	33.78 Million EUR	0.0%
2010 FY	33.78 Million EUR	24.59%
2009 Q4	27.11 Million EUR	0.0%
2009 FY	27.11 Million EUR	315.0%
2008 FY	6.53 Million EUR	0.0%
2007 FY	- EUR	-100.0%
2006 FY	42.49 Million EUR	-16.64%
2005 FY	50.97 Million EUR	0.0%

Peer Total Debt Comparison of Vetoquinol SA

Name	Total Debt	Total Debt Difference
Boiron SA	13.7 Million EUR	-28.653%
Laboratorios Farmaceuticos Rovi, S.A.	46.63 Million EUR	62.2%
Valneva SE	208.81 Million EUR	91.558%
AB Science S.A.	19.1 Million EUR	7.712%
Nanobiotix S.A.	45.48 Million EUR	61.243%
PHAXIAM Therapeutics S.A.	10.19 Million EUR	-72.84%
Vivoryon Therapeutics N.V.	38 Thousand EUR	-46289.474%
BioSenic S.A.	28.16 Million EUR	37.403%
ABIVAX Société Anonyme	55.46 Million EUR	68.217%
Formycon AG	29.48 Million EUR	40.216%